Principal Financial Group Inc. Reduces Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Principal Financial Group Inc. cut its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 4.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 248,636 shares of the company's stock after selling 11,842 shares during the quarter. Principal Financial Group Inc. owned 0.50% of Prestige Consumer Healthcare worth $17,927,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of PBH. Covestor Ltd raised its stake in shares of Prestige Consumer Healthcare by 21.6% in the first quarter. Covestor Ltd now owns 834 shares of the company's stock worth $61,000 after purchasing an additional 148 shares during the last quarter. Evergreen Capital Management LLC raised its position in shares of Prestige Consumer Healthcare by 5.4% during the 2nd quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company's stock valued at $216,000 after buying an additional 160 shares in the last quarter. Miller Howard Investments Inc. NY lifted its stake in Prestige Consumer Healthcare by 2.2% during the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company's stock worth $534,000 after purchasing an additional 165 shares during the last quarter. OLD National Bancorp IN lifted its position in Prestige Consumer Healthcare by 4.4% in the 3rd quarter. OLD National Bancorp IN now owns 3,974 shares of the company's stock worth $287,000 after buying an additional 168 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock valued at $33,000 after acquiring an additional 208 shares during the period. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Adel Mekhail sold 9,063 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total value of $743,166.00. Following the transaction, the executive vice president now owns 18,365 shares of the company's stock, valued at $1,505,930. This represents a 33.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider William P'pool sold 8,987 shares of the firm's stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $81.85, for a total value of $735,585.95. Following the transaction, the insider now directly owns 20,058 shares in the company, valued at approximately $1,641,747.30. The trade was a 30.94 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 27,935 shares of company stock valued at $2,289,025. 1.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on PBH. Jefferies Financial Group reiterated a "hold" rating and set a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson reissued a "buy" rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a report on Monday. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $94.20.

Prestige Consumer Healthcare Stock Down 0.5 %

Prestige Consumer Healthcare stock traded down $0.44 during midday trading on Friday, reaching $82.36. The company's stock had a trading volume of 285,591 shares, compared to its average volume of 250,820. The stock's 50-day simple moving average is $73.13 and its 200-day simple moving average is $70.18. The stock has a market capitalization of $4.07 billion, a P/E ratio of 20.04, a PEG ratio of 2.32 and a beta of 0.47. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.56 and a quick ratio of 2.10. Prestige Consumer Healthcare Inc. has a 52-week low of $56.61 and a 52-week high of $83.83.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting analysts' consensus estimates of $1.09. The firm had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company's revenue was down .9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.07 earnings per share. On average, sell-side analysts expect that Prestige Consumer Healthcare Inc. will post 4.45 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.